Skip to Content

We invite you to try out our new beta eCFR site at We’ve made big changes to make the eCFR easier to use. Be sure to leave feedback using the 'Feedback' button on the bottom right of each page!


Meeting of the Advisory Committee on Infant Mortality

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS).




In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Committee on Infant Mortality (ACIM) has scheduled a public meeting. Information about ACIM and the agenda for this meeting can be found on the ACIM website at​advisory-committees/​infant-mortality/​index.html.


January 25, 2021, 11:00 a.m.-6:00 p.m. Eastern Time (ET) and January 26, 2021, 11:00 a.m.-3:30 p.m. ET.


This meeting will be held via webinar. The webinar link and log-in information will be available at ACIM's website before the meeting:​advisory-committees/​infant-mortality/​index.html.

Start Further Info


David S. de la Cruz, Ph.D., MPH, Designated Federal Official, Maternal and Child Health Bureau (MCHB), HRSA, 5600 Fishers Lane, Room 18N25, Rockville, Maryland 20857; 301-443-0543; or

End Further Info End Preamble Start Supplemental Information


The ACIM is authorized by section 222 of the Public Health Service Act (42 U.S.C. 217a), as amended. The Committee is governed by provisions of Public Law 92-463, as amended, (5 U.S.C. App. 2), which sets forth standards for the formation and use of Advisory Committees.

The ACIM advises the Secretary of HHS on department activities and programs directed at reducing infant mortality and improving the health status of pregnant women and infants. The ACIM represents a public-private partnership at the highest level to provide guidance and focus attention on the policies and resources required to address the reduction of infant mortality and the improvement of the health status of pregnant women and infants. With a focus on life course, the ACIM addresses disparities in maternal health to improve maternal health outcomes, including preventing and reducing maternal mortality and severe maternal morbidity. The ACIM provides advice on how best to coordinate myriad federal, state, local, and private programs and efforts that are designed to deal with the health and social problems impacting infant mortality and maternal health, including implementation of the Healthy Start Start Printed Page 83588program and maternal and infant health objectives from the National Health Promotion and Disease Prevention Objectives (i.e., Healthy People 2030).

The agenda for the January 25 and 26, 2021, meeting is being finalized and may include the following: Updates from HRSA, MCHB, and other federal agencies; continued discussion of the impact of COVID-19 on infant and maternal health; immigrant maternal and child health issues; environmental contributions to infant mortality and maternal mortality; and updates on priority topic areas for ACIM to address (equity, data, access, and quality of care). Agenda items are subject to change as priorities dictate. Refer to the ACIM website for any updated information concerning the meeting.

Members of the public will have the opportunity to provide written or oral comments. Requests to submit a written statement or make oral comments to the ACIM should be sent to David S. de la Cruz, using the email address above at least 3 business days prior to the meeting. Public participants may submit written statements in advance of the scheduled meeting by emailing Oral comments will be honored in the order they are requested and may be limited as time allows.

Individuals who plan to attend and need special assistance or another reasonable accommodation should notify David S. de la Cruz at the contact information listed above at least 10 business days prior to the meeting.

Start Signature

Maria G. Button,

Director, Executive Secretariat.

End Signature End Supplemental Information

[FR Doc. 2020-28163 Filed 12-21-20; 8:45 am]